Programmed cell death protein-1 inhibitor combined with chimeric antigen receptor T cells in the treatment of relapsed refractory non-Hodgkin lymphoma: A case report

Added 385 days ago (28.04.2021)

Authors: Zhi-Yun Niu; Li Sun; Shu-Peng Wen; Zheng-Rong Song; Lina Xing; Ying Wang; Jian-Qiang Li; Xue-Jun Zhang; Fu-Xu Wang